The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 07, 2023
Filed:
Jan. 04, 2021
Applicant:
Bavarian Nordic A/s, Hellerup, DK;
Inventors:
Robin Steigerwald, Munich, DE;
Markus Kalla, Penzberg, DE;
Assignee:
Bavarian Nordic A/S, Hellerup, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/863 (2006.01); A61K 39/15 (2006.01); A61K 39/12 (2006.01); C12N 15/86 (2006.01); C07K 14/005 (2006.01); A61P 31/14 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/15 (2013.01); A61K 39/12 (2013.01); A61P 31/14 (2018.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/545 (2013.01); C12N 2710/24134 (2013.01); C12N 2710/24143 (2013.01); C12N 2710/24171 (2013.01); C12N 2720/12134 (2013.01); C12N 2720/12143 (2013.01); C12N 2720/12171 (2013.01); C12N 2770/36134 (2013.01);
Abstract
The present invention relates to recombinant modified vaccinia virus Ankara (MVA) and to methods of using the same. In particular, the invention relates to recombinant MVA comprising a nucleotide sequence encoding for a structural protein of an equine encephalitis virus (EEV) excluding encoding for a capsid protein of the EEV, a composition in particular a pharmaceutical composition, a vaccine or kit comprising the recombinant MVA, uses and methods thereof e.g., suitable for treating and/or preventing a western, Venezuelan, and/or eastern equine encephalitis virus caused disease.